caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1649486010

Chelsea GordnerDO/MPH

EndocrinologyMiramar, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Chelsea Gordner's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 28 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BAYSTATE MEDICAL CENTER INC191751
BRODER, MARTIN47237
Rhett Krause
Diagnostic Radiology · Springfield, MA
31207
Ibitoro Osakwe
Endocrinology · Hartford, CT
2946
Michael Swirsky
Diagnostic Radiology · Springfield, MA
2677
Christopher Moore
Diagnostic Radiology · Springfield, MA
2589
Neha Malhotra
Endocrinology · Springfield, MA
2437
William Hiser
Cardiology · Springfield, MA
2386
Eugene Kang
Diagnostic Radiology · Plymouth, MA
2287
Jiuming Ye
Nephrology · Springfield, MA
19118
MEDCARE EMERGENCY HEALTH, INC.1947
Alena Kreychman
Diagnostic Radiology · Farmington, CT
1864
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
141
Unique beneficiaries
—
Total services
214
Distinct HCPCS
7
Medicare payment
$17K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 415 Endocrinology providers in FL — bottom quintile (cohort median 962).
PRESCRIBING · PART D · 2024
Total Rx claims
546
Beneficiaries
—
Total drug cost
$236K
Distinct drugs
16
Brand share
76.0%
Top prescribed drugs
Tirzepatide66 claims
Semaglutide60 claims
Insulin Glargine,hum.Rec.Anlog56 claims
Levothyroxine Sodium52 claims
Insulin Lispro30 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$13
Payment records
1
By payment type
Food and Beverage$13